The best way to administer steroids for sudden sensorineural hearing loss (SSHL) is still unclear. The present study was aimed at estimating the efficacy of steroids by intratympanic, systemic, and combined therapy (CT) routes.
Methods:
A systematic literature search was performed from 1950 to October 2019 for randomized controlled trials comparing the use of intratympanic, systemic, and combined steroid therapy for SSHL. The outcomes of recovery rate and pure tone average (PTA) improvement were assessed by random-effects and fixed-effects meta-analysis.
Results:
A total of 20 articles identified from 7 countries were eligible for analysis. Although no significant difference in recovery rate was observed between intratympanic steroid therapy (IST) and systemic steroid therapy (SST), IST did demonstrate better hearing improvement, as evidenced by a higher PTA than SST. Compared with SST, CT comprising IST and SST had significant recovery rate improvement. Patients treated with CT had a significantly higher PTA than those treated with SST. Through subgroup analysis based on the equivalent dose of prednisone, it was shown that CT led to a significantly higher PTA than SST only in the high-dose CT versus high-dose SST groups and moderate-dose CT versus high-dose SST groups.
Conclusion:
Moderate and high dose of CT could accelerate hearing improvement in SSHL.
WilsonWRBylFMLairdN.The efficacy of steroids in the treatment of idiopathic sudden hearing loss: a double-blind clinical study. Arch Otolaryngol. 1980;106:772-776. doi:10.1001/archotol.1980.00790360050013
2.
RauchSDHalpinCFAntonelliPJ, et al. Oral vs intratympanic corticosteroid therapy for idiopathic sudden sensorineural hearing loss: a randomized trial. JAMA. 2011;305:2071-2079. doi:10.1001/jama.2011.679
3.
KuhnMHeman-AckahSEShaikhJARoehmPC.Sudden sensorineural hearing loss: a review of diagnosis, treatment, and prognosis. Trends Amplif. 2011;15:91-105. doi:10.1177/1084713811408349
4.
FazelMTJedlowskiPMCravensRBJrErstadBL.Evaluation and treatment of acute and subacute hearing loss: a review of pharmacotherapy. Pharmacotherapy. 2017;37:1600-1616. doi:10.1002/phar.2044
5.
ChawkiSAouizerateJTradSPrinseauJHanslikT.Bilateral sudden sensorineural hearing loss as a presenting feature of systemic lupus erythematosus: case report and brief review of other published cases. Medicine (Baltimore). 2016;95:e4345. doi:10.1097/md.0000000000004345
6.
TanakaMTanakaK.Sudden hearing loss as the initial symptom in Japanese patients with multiple sclerosis and seropositive neuromyelitis optica spectrum disorders. J Neuroimmunol. 2016;298:16-18. doi:10.1016/j.jneuroim.2016.06.004
7.
TirelliGTomiettoPQuatelaE, et al. Sudden hearing loss and Crohn disease: when Cogan syndrome must be suspected. Am J Otolaryngol. 2015;36:590-597. doi:10.1016/j.amjoto.2015.02.013
8.
LiGYouDMaJLiWLiHSunS.The role of autoimmunity in the pathogenesis of sudden sensorineural hearing loss. 2018;2018:7691473. doi:10.1155/2018/7691473
9.
LloydSK.Sudden sensorineural hearing loss: early diagnosis improves outcome. Br J Gen Pract. 2013;63:e592-e594. doi:10.3399/bjgp13X670877
10.
BattagliaABurchetteRCuevaR.Combination therapy (intratympanic dexamethasone + high-dose prednisone taper) for the treatment of idiopathic sudden sensorineural hearing loss. Otol Neurotol. 2008;29:453-460. doi:10.1097/MAO.0b013e318168da7a
11.
XieLHouJQiHDaiYSheW. Histone acetylation in refractory sudden sensorineural hearing loss patients after intratympanic methylprednisolone perfusion [published online September 11, 2019]. J Laryngol Otol. doi:10.1017/s0022215119001865
12.
FilipoRAttanasioGCagnoniL, et al. Long-term results of intratympanic prednisolone injection in patients with idiopathic sudden sensorineural hearing loss. Acta Otolaryngol. 2013;133:900-904. doi:10.3109/00016489.2013.788791
13.
SwachiaKSharmaDSinghJ. Efficacy of oral vs. intratympanic corticosteroids in sudden sensorineural hearing loss. J Basic Clin Physiol Pharmacol. 2016;27:371-377. doi:10.1515/jbcpp-2015-0112
14.
ErmutluGSüslüNYilmazTSaracS.Sudden hearing loss: an effectivity comparison of intratympanic and systemic steroid treatments. Eur Arch Otorhinolaryngol. 2017;274:3585-3591. doi:10.1007/s00405-017-4691-8
15.
AshtianiMKFirouziFBastaninejadS, et al. Efficacy of systemic and intratympanic corticosteroid combination therapy versus intratympanic or systemic therapy in patients with idiopathic sudden sensorineural hearing loss: a randomized controlled trial. Eur Arch Otorhinolaryngol. 2018;275:89-97. doi:10.1007/s00405-017-4808-0
16.
MoherDLiberatiATetzlaffJAltmanDG; PRISMA Group. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement. Ann Intern Med. 2009;151:264-269. doi:10.7326/0003-4819-151-4-200908180-00135
17.
StachlerRJChandrasekharSSArcherSM, et al; American Academy of Otolaryngology-Head and Neck Surgery. Clinical practice guideline: sudden hearing loss. Otolaryngol Head Neck Surg. 2012;146(3, suppl):S1-S35. doi:10.1177/0194599812436449
18.
HigginsJPAltmanDGGotzschePC, et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928. doi:10.1136/bmj.d5928
19.
EggerMSmithGDSchneiderMMinderC.Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629-634. doi:10.1136/bmj.315.7109.629
20.
HigginsJPThompsonSGDeeksJJAltmanDG.Measuring inconsistency in meta-analyses. BMJ. 2003;327:557-560. doi:10.1136/bmj.327.7414.557
21.
GuyattGHOxmanADVistGE, et al; GRADE Working Group. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336:924-926. doi:10.1136/bmj.39489.470347.AD
22.
XenellisJPapadimitriouNNikolopoulosT, et al. Intratympanic steroid treatment in idiopathic sudden sensorineural hearing loss: a control study. Otolaryngol Head Neck Surg. 2006;134:940-945. doi:10.1016/j.otohns.2005.03.081
23.
AhnJHYooMHYoonTHChungJW.Can intratympanic dexamethasone added to systemic steroids improve hearing outcome in patients with sudden deafness?Laryngoscope. 2008;118:279-282. doi:10.1097/MLG.0b013e3181585428
24.
HongSMParkCHLeeJH.Hearing outcomes of daily intratympanic dexamethasone alone as a primary treatment modality for ISSHL. Otolaryngol Head Neck Surg. 2009;141:579-583. doi:10.1016/j.otohns.2009.08.009
25.
ArslanNOguzHDemirciM, et al. Combined intratympanic and systemic use of steroids for idiopathic sudden sensorineural hearing loss. Otol Neurotol. 2011;32:393-397. doi:10.1097/MAO.0b013e318206fdfa
26.
LeeJBChoiSJParkKParkHYChooOSChoungYH.The efficiency of intratympanic dexamethasone injection as a sequential treatment after initial systemic steroid therapy for sudden sensorineural hearing loss. Eur Arch Otorhinolaryngol. 2011;268:833-839. doi:10.1007/s00405-010-1476-8
Khorsandi AshtianiMTBorgheiePYazdaniNMaghsoudS.The effect of intratympanic dexamethasone with oral prednisolone as a primary treatment in idiopathic sudden sensorineural hearing loss. Iran J Otorhinolaryngol. 2012;24:19-22.
29.
ArastouSTajediniABorgheiP.Combined intratympanic and systemic steroid therapy for poor-prognosis sudden sensorineural hearing loss. Iran J Otorhinolaryngol. 2013;25:23-28.
30.
GundoganOPinarEImreAOzturkcanSCokmezOYigiterAC.Therapeutic efficacy of the combination of intratympanic methylprednisolone and oral steroid for idiopathic sudden deafness. Otolaryngol Head Neck Surg. 2013;149:753-758. doi:10.1177/0194599813500754
31.
KoltsidopoulosPBibasASismanisATzonouASeggasI.Intratympanic and systemic steroids for sudden hearing loss. Otol Neurotol. 2013;34:771-776. doi:10.1097/MAO.0b013e31828bb567
32.
LimHJKimYTChoiSJ, et al. Efficacy of 3 different steroid treatments for sudden sensorineural hearing loss: a prospective, randomized trial. Otolaryngol Head Neck Surg. 2013;148:121-127. doi:10.1177/0194599812464475
33.
LvZTangZWDengLB.Clinical effect of dual pathways combined with hormone in the treatment of sudden deafness. Hainan Med J. 2013;(17):2564-2566.
34.
BattagliaALualhatiALinHBurchetteRCuevaR.A prospective, multi-centered study of the treatment of idiopathic sudden sensorineural hearing loss with combination therapy versus high-dose prednisone alone: a 139 patient follow-up. Otol Neurotol. 2014;35:1091-1098. doi:10.1097/mao.0000000000000450
35.
XueYQZhuHWRuanYJ.Clinical effect of intratympanic dexamethasone perfusion in the treatment of sudden deafness. J Clin Exp Med. 2014;13:1159-1161.
36.
TsounisMPsillasGTsalighopoulosMVitalVMaroudiasNMarkouK.Systemic, intratympanic and combined administration of steroids for sudden hearing loss: a prospective randomized multicenter trial. Eur Arch Otorhinolaryngol. 2018;275:103-110. doi:10.1007/s00405-017-4803-5
37.
LiJYuLXiaRGaoFLuoWJingY.Postauricular hypodermic injection to treat inner ear disorders: experimental feasibility study using magnetic resonance imaging and pharmacokinetic comparison. J Laryngol Otol. 2013;127:239-245. doi:10.1017/s0022215113000017
38.
BirdPAMurrayDPZhangMBeggEJ.Intratympanic versus intravenous delivery of dexamethasone and dexamethasone sodium phosphate to cochlear perilymph. Otol Neurotol. 2011;32:933-936. doi:10.1097/MAO.0b013e3182255933
39.
El SabbaghNGSewitchMJBezdjianADanielSJ.Intratympanic dexamethasone in sudden sensorineural hearing loss: a systematic review and meta-analysis. Laryngoscope. 2017;127:1897-1908. doi:10.1002/lary.26394
40.
ZhaoDTongBWangQHellstromSDuanM.A comparison of effects of systemic and intratympanic steroid therapies for sudden sensorineural hearing loss: a meta-analysis. J Otol. 2016;11:18-23. doi:10.1016/j.joto.2016.02.002
41.
ParnesLSSunAHFreemanDJ.Corticosteroid pharmacokinetics in the inner ear fluids: an animal study followed by clinical application. Laryngoscope. 1999;109(7, pt 2):1-17. doi:10.1097/00005537-199907001-00001
42.
ChandrasekharSSRubinsteinRYKwartlerJA, et al. Dexamethasone pharmacokinetics in the inner ear: comparison of route of administration and use of facilitating agents. Otolaryngol Head Neck Surg. 2000;122:521-528. doi:10.1067/mhn.2000.102578
43.
ChiFLYangMQZhouYDWangB.Therapeutic efficacy of topical application of dexamethasone to the round window niche after acoustic trauma caused by intensive impulse noise in guinea pigs. J Laryngol Otol. 2011;125:673-685. doi:10.1017/s0022215111000028
44.
OzdoganFEnsariSCakirO, et al. Investigation of the cochlear effects of intratympanic steroids administered following acoustic trauma. Laryngoscope. 2012;122:877-882. doi:10.1002/lary.23185
45.
ChenLDeanCGandolfiMNahmEMattiaceLKimAH.Dexamethasone’s effect in the retrocochlear auditory centers of a noise-induced hearing loss mouse model. Otolaryngol Head Neck Surg. 2014;151:667-674. doi:10.1177/0194599814545771
46.
WesterlakenBOde KleineEvan der LaanBAlbersF.The treatment of idiopathic sudden sensorineural hearing loss using pulse therapy: a prospective, randomized, double-blind clinical trial. Laryngoscope. 2007;117:684-690. doi:10.1097/mlg.0b013e3180316d3b
47.
SeggasIKoltsidopoulosPBibasATzonouASismanisA.Intratympanic steroid therapy for sudden hearing loss: a review of the literature. Otol Neurotol. 2011;32:29-35. doi:10.1097/mao.0b013e3181f7aba3
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
